August 09, 2019
American Health Packaging is recalling 6579 cartons of doxycycline hyclate tablets because samples failed to meet dissolution specifications during routine testing, according to the August 7, 2019, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects doxycycline hyclate tablets, 100 mg (NDC 62584-693-11), 30 tablets per carton (3x10 unit dose blister packs, NDC 62584-693-21) from lot 172569 (Exp. 7/31/19). The tablets were distributed throughout the United States.
American Health Packaging voluntarily initiated the recall August 1, 2019. The FDA designated the recall Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.
Doxycycline hyclate is a prescription tetracycline antibiotic used to treat bacterial infections and to prevent malaria.